Aevi Genomic Medicine
Financials
Estimates*
USD | 2016 |
---|---|
R&D budget | 29.7m |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $21.0m | Post IPO Equity | |
N/A | $3.4m | Grant | |
$28.0m | Post IPO Equity | ||
N/A | $4.9m | Post IPO Equity | |
N/A | N/A | Acquisition | |
Total Funding | €18.1m |
Related Content
Recent News about Aevi Genomic Medicine
EditAevigenomics is a pioneering startup in the biotechnology sector, focusing on advanced genomic solutions. The company leverages cutting-edge technology to analyze and interpret genetic data, providing actionable insights for personalized healthcare. Aevigenomics primarily serves healthcare providers, research institutions, and pharmaceutical companies. These clients use the company's genomic data to develop targeted treatments, conduct research, and improve patient outcomes.
Operating in the rapidly growing genomics market, Aevigenomics stands out by offering comprehensive genomic analysis services. This market is driven by the increasing demand for personalized medicine, where treatments are tailored to an individual's genetic makeup. By providing detailed genetic insights, Aevigenomics helps its clients make informed decisions, leading to more effective and efficient healthcare solutions.
The business model of Aevigenomics is based on a service-oriented approach. They offer genomic sequencing and analysis services on a subscription or per-project basis. This means clients either pay a recurring fee for ongoing access to their services or a one-time fee for specific projects. Additionally, Aevigenomics may partner with pharmaceutical companies for research and development projects, generating revenue through collaborative agreements.
Aevigenomics makes money by charging for its genomic analysis services. These services include sequencing DNA, interpreting genetic data, and providing detailed reports that help clients understand the genetic factors influencing health and disease. By offering high-quality, reliable data, Aevigenomics ensures that its clients can trust the insights they receive, which is crucial for making critical healthcare decisions.
In summary, Aevigenomics is a key player in the genomics market, providing essential services that enable personalized healthcare. Their business model focuses on delivering high-value genomic insights through a combination of subscription and project-based fees.
Keywords: Genomics, Biotechnology, Personalized Healthcare, Genetic Data, DNA Sequencing, Research Institutions, Pharmaceutical Companies, Genomic Analysis, Healthcare Providers, Subscription Services.